Chinese english Germany Japanese Korea

1-Pyridin-2-ylMethyl-piperidin-3-ylaMine dihydrochloride, 98+% C11H19Cl2N3, MW: 264.19

1-Pyridin-2-ylMethyl-piperidin-3-ylaMine dihydrochloride, 98+% C11H19Cl2N3, MW: 264.19 Struktur
1185312-66-6
CAS-Nr.
1185312-66-6
Englisch Name:
1-Pyridin-2-ylMethyl-piperidin-3-ylaMine dihydrochloride, 98+% C11H19Cl2N3, MW: 264.19
Synonyma:
1-(2-Pyridinylmethyl)-3-piperidinamine hydrochloride;1-(PYRIDIN-2-YLMETHYL)PIPERIDIN-3-AMINE DIHYDROCHLORIDE;1-Pyridin-2-ylMethyl-piperidin-3-ylaMine dihydrochloride, 98+% C11H19Cl2N3, MW: 264.19
CBNumber:
CB12593237
Summenformel:
C11H19Cl2N3
Molgewicht:
264.19466
MOL-Datei:
1185312-66-6.mol
Request For Quotation

1-Pyridin-2-ylMethyl-piperidin-3-ylaMine dihydrochloride, 98+% C11H19Cl2N3, MW: 264.19 Eigenschaften

Sicherheit

1-Pyridin-2-ylMethyl-piperidin-3-ylaMine dihydrochloride, 98+% C11H19Cl2N3, MW: 264.19 Chemische Eigenschaften,Einsatz,Produktion Methoden

1-Pyridin-2-ylMethyl-piperidin-3-ylaMine dihydrochloride, 98+% C11H19Cl2N3, MW: 264.19 Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

1-Pyridin-2-ylMethyl-piperidin-3-ylaMine dihydrochloride, 98+% C11H19Cl2N3, MW: 264.19 Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 6)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Alchem Pharmtech,Inc. 		8485655694
sales@alchempharmtech.com United States 63711 58
CONIER CHEM AND PHARMA LIMITED 		+8618523575427
 sales@conier.com China 49392 58
Hangzhou MolCore BioPharmatech Co.,Ltd. 		+86-057181025280; +8617767106207
 sales@molcore.com China 49739 58
Meryer (Shanghai) Chemical Technology Co., Ltd. 021-61259108 18621169109
 market03@meryer.com China 40240 62
Amber MolTech LLC 086-010-62176588
amber@jyamber.com China 10152 56
  • 1-Pyridin-2-ylMethyl-piperidin-3-ylaMine dihydrochloride, 98+% C11H19Cl2N3, MW: 264.19
  • 1-(2-Pyridinylmethyl)-3-piperidinamine hydrochloride
  • 1-(PYRIDIN-2-YLMETHYL)PIPERIDIN-3-AMINE DIHYDROCHLORIDE
  • 1185312-66-6
Copyright 2019 © ChemicalBook. All rights reserved